Investigation of Bromelain, Inulin and Saccharomyces cerevisiae Effects Against Escherichia coli Infection Developed in Fibroblast Wound Model; [Bromelain, İnulin ve Saccharomyces cerevisiae’nin Fibroblast Yara Modelinde Gelişen Escherichia coli Enfeksiyonuna Karşı Etkilerinin Araştırılması]

ArticleAçık Erişim

Özet

Aim: Wound infections, especially in today’s world where antibiotic resistance is increasing, pose a serious health problem. Escherichia coli complicates treatment by forming a biofilm. In this study, the individual and combined effects of bromelain, inulin, and Saccharomyces cerevisiae on an Escherichia coli infection model created in fibroblast cells were investigated. Methods: The antibacterial activity of bromelain, inulin, and Saccharomyces cerevisiae was evaluated using the disk diffusion method; minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), and fractional inhibitory concentration (FIC) analyses were conducted. Biofilm inhibitory activity was evaluated using the crystal violet staining method. In vitro wound model has been created using human fibroblast cells. Bromelain, inulin, and Saccharomyces cerevisiae agents were applied to the cells infected with Escherichia coli. Cell viability was determined by the MTT test and analyzed through measurements of total oxidant status (TOS) and total antioxidant capacity (TAC). To evaluate the inflammatory response, IL-1β and IL-10 levels were quantitatively measured using the ELISA method. Results: According to disk diffusion, MIC/MBC, FIC, and antibiofilm analyses, it has been determined that the triple combination (Bromelain + Inulin + Saccharomyces cerevisiae) provides the highest antibacterial and synergistic effect. In the antibiofilm tests, bromelain showed the strongest inhibitory effect (58.3%), but the effect of the triple combination was more limited. In the MTT analysis, cell viability increased in the treatment groups, reaching 112% especially in the triple combination. While TOS levels increased with infection, they significantly decreased after treatment, whereas TAC levels increased. In ELISA analyses, the IL-1β level significantly increased with infection, but decreased with treatment. IL-10 levels, on the other hand, significantly increased, especially in the triple combination, demonstrating an anti-inflammatory response. Conclusions: The combination of bromelain, inulin, and Saccharomyces cerevisiae has shown antimicrobial, antioxidant, and anti-inflammatory activity against Escherichia coli infection, thereby supporting wound healing. © 2025, Selcuk University. All rights reserved.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/10576Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.54005/geneltip.1737789Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorBaşer, Sümeyye
dc.contributor.authorÇelebi, Demet
dc.contributor.authorÇelebi, Özgür
dc.contributor.authorGenç, Sıdıka Tülay
dc.contributor.authorTaghizadehghalehjoughi, Ali
dc.date.accessioned2026-10-18T20:25:46.165745401Z
dc.date.available2026-10-18T20:25:46.165745401Z
dc.date.issued2025
dc.description.abstractAim: Wound infections, especially in today’s world where antibiotic resistance is increasing, pose a serious health problem. Escherichia coli complicates treatment by forming a biofilm. In this study, the individual and combined effects of bromelain, inulin, and Saccharomyces cerevisiae on an Escherichia coli infection model created in fibroblast cells were investigated. Methods: The antibacterial activity of bromelain, inulin, and Saccharomyces cerevisiae was evaluated using the disk diffusion method; minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), and fractional inhibitory concentration (FIC) analyses were conducted. Biofilm inhibitory activity was evaluated using the crystal violet staining method. In vitro wound model has been created using human fibroblast cells. Bromelain, inulin, and Saccharomyces cerevisiae agents were applied to the cells infected with Escherichia coli. Cell viability was determined by the MTT test and analyzed through measurements of total oxidant status (TOS) and total antioxidant capacity (TAC). To evaluate the inflammatory response, IL-1β and IL-10 levels were quantitatively measured using the ELISA method. Results: According to disk diffusion, MIC/MBC, FIC, and antibiofilm analyses, it has been determined that the triple combination (Bromelain + Inulin + Saccharomyces cerevisiae) provides the highest antibacterial and synergistic effect. In the antibiofilm tests, bromelain showed the strongest inhibitory effect (58.3%), but the effect of the triple combination was more limited. In the MTT analysis, cell viability increased in the treatment groups, reaching 112% especially in the triple combination. While TOS levels increased with infection, they significantly decreased after treatment, whereas TAC levels increased. In ELISA analyses, the IL-1β level significantly increased with infection, but decreased with treatment. IL-10 levels, on the other hand, significantly increased, especially in the triple combination, demonstrating an anti-inflammatory response. Conclusions: The combination of bromelain, inulin, and Saccharomyces cerevisiae has shown antimicrobial, antioxidant, and anti-inflammatory activity against Escherichia coli infection, thereby supporting wound healing. © 2025, Selcuk University. All rights reserved.
dc.identifier.doi10.54005/geneltip.1737789
dc.identifier.eissn2602-3741
dc.identifier.endpage265
dc.identifier.issn2602-3741
dc.identifier.issue6
dc.identifier.scopus2-s2.0-105030283002
dc.identifier.startpage253
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/10576
dc.identifier.volume35
dc.language.isoen
dc.publisherSelcuk University
dc.relation.ispartofGenel Tip Dergisi
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectBromelain
dc.subjectescherichia coli
dc.subjectinulin
dc.subjectsaccharomyces cerevisiae
dc.subjectwound infection
dc.subjectinterleukin 10
dc.subjectinterleukin 1beta
dc.subjectantibacterial activity
dc.subjectantibiofilm activity
dc.subjectantibiotic sensitivity
dc.subjectantiinflammatory activity
dc.subjectantioxidant activity
dc.subjectArticle
dc.subjectbiofilm
dc.subjectcell viability
dc.subjectdisk diffusion
dc.subjectenzyme linked immunosorbent assay
dc.subjectEscherichia coli infection
dc.subjectfibroblast
dc.subjectfractional inhibitory concentration
dc.subjecthuman
dc.subjecthuman cell
dc.subjectinflammation
dc.subjectminimum bactericidal concentration
dc.subjectminimum inhibitory concentration
dc.subjectMTT assay
dc.subjectnonhuman
dc.subjectspectrophotometry
dc.subjecttotal antioxidant capacity
dc.subjectwound
dc.titleInvestigation of Bromelain, Inulin and Saccharomyces cerevisiae Effects Against Escherichia coli Infection Developed in Fibroblast Wound Model; [Bromelain, İnulin ve Saccharomyces cerevisiae’nin Fibroblast Yara Modelinde Gelişen Escherichia coli Enfeksiyonuna Karşı Etkilerinin Araştırılması]
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus1
rdl.citation.trdizin0
rdl.departmentBİLECİK ŞEYH EDEBALİ ÜNİVERSİTESİ
rdl.departmentATATÜRK ÜNİVERSİTESİ
rdl.departmentERZİNCAN BİNALİ YILDIRIM ÜNİVERSİTESİ
rdl.oa.statusgold
rdl.source.indexSCOPUS
rdl.source.indexTRDIZIN